Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Represents ABM In Its US$275 Million Acquisition of WGNSTARDecember 17, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025Sidley Advises Ancala on Acquisition of U.S. Chemical Infrastructure PortfolioDecember 4, 2025Sidley Represents Jane Street in Investments in Kraken and X-EnergyDecember 3, 2025Sidley Represents PayRange in Its Acquisition of KioSoftDecember 1, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory